Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

United Therapeutics

Tracked across 7 events · 45 articles · First seen Jan 25, 2025 · Last active Sep 23, 2026

Sentiment
31
Attention
4
Events
7
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: United Therapeutics initiated a Phase 2 clinical trial for its EGCg-based investigational therapy for precancerous cervical lesions, which could significantly advance its product pipeline and market position.
May 19, 2026 · 7 articles
4 70
Business
Impact: United Therapeutics acquired Thymmune Therapeutics, Inc. for $140 million in cash, with potential earn-out payments up to $160 million. This acquisition expands United Therapeutics' capabilities in regenerative medicine and organ alternatives, aligning with its mission to address rare diseases and organ supply.
Jul 02, 2026 · 7 articles
1 10
Business
Impact: United Therapeutics appointed Victor Dzau to its board and increased board size, signaling governance enhancement and strategic guidance for its mission in rare diseases and organ transplantation.
Jul 23, 2026 · 6 articles
4 70
Regulatory
Impact: United Therapeutics is the sponsor of the NDA and the developer of ralinepag. The FDA acceptance is a key regulatory milestone that could lead to a new product launch and revenue growth.
Aug 24, 2026 · 7 articles
2 0
Business
Lunai Bioworks announced an exclusive worldwide license and collaboration agreement with Tanaist to add human cellular phenotyping to its Parkinson's disease discovery and validation platform. Under the deal, Lunai gains exclusive rights to Tanaist's licensed…
Impact: United Therapeutics is referenced as Lunai's prior August 2026 collaboration partner, forming part of Lunai's broader Parkinson's strategy. The new Tanaist deal does not directly alter BrainStorm's position.
Sep 22, 2026 · 6 articles
2 0
Business
Impact: United Therapeutics was one of the presenting companies at the Life Sciences Virtual Investor Forum.
Jun 26, 2026 · 6 articles
4 0
Business
Apr 08, 2026 · 6 articles
3D Systems development partner ↔ United Therapeutics United Therapeutics partners with 3D Systems to leverage their advanced bioprint
3D Systems technology partner ↔ United Therapeutics 3D Systems acts as a critical technology partner to United Therapeutics, supplyi
ERGEN INTELLIGENCE
Track United Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.